Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy

Ann Hematol. 2004 Sep;83(9):608-10. doi: 10.1007/s00277-004-0897-0. Epub 2004 Jun 16.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Blister / blood
  • Blister / pathology
  • Cyclophosphamide / therapeutic use*
  • Doxorubicin / therapeutic use*
  • Female
  • Herpesvirus 4, Human / genetics
  • Herpesvirus 4, Human / isolation & purification
  • Humans
  • Immunohistochemistry
  • Killer Cells, Natural / metabolism
  • Killer Cells, Natural / pathology
  • Leg / pathology
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, B-Cell / pathology
  • Prednisone / therapeutic use*
  • Recurrence
  • Rituximab
  • Telangiectasis / pathology
  • Vincristine / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol